Peer Review reports
From: MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1
| Original Submission | ||
|---|---|---|
| 18 Jun 2019 | Submitted | Original manuscript |
| 15 Jul 2019 | Reviewed | Reviewer Report - Naoki Oishi |
| 19 Jul 2019 | Reviewed | Reviewer Report - Chang-Han Chen |
| 20 Aug 2019 | Author responded | Author comments - Wei Zhang |
| Resubmission - Version 2 | ||
| 20 Aug 2019 | Submitted | Manuscript version 2 |
| 3 Sep 2019 | Reviewed | Reviewer Report - Naoki Oishi |
| 26 Sep 2019 | Reviewed | Reviewer Report - Chang-Han Chen |
| 15 Oct 2019 | Author responded | Author comments - Wei Zhang |
| Resubmission - Version 3 | ||
| 15 Oct 2019 | Submitted | Manuscript version 3 |
| 27 Oct 2019 | Reviewed | Reviewer Report - Naoki Oishi |
| 28 Oct 2019 | Reviewed | Reviewer Report - Chang-Han Chen |
| 30 Oct 2019 | Author responded | Author comments - Wei Zhang |
| Resubmission - Version 4 | ||
| 30 Oct 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 31 Oct 2019 | Editorially accepted | |
| 12 Nov 2019 | Article published | 10.1186/s12885-019-6319-4 |
You can find further information about peer review here.